{"id":2813,"date":"2022-08-15T05:10:06","date_gmt":"2022-08-15T10:10:06","guid":{"rendered":"https:\/\/www.molllawgroup.com\/blog\/?p=2813"},"modified":"2022-08-06T19:10:58","modified_gmt":"2022-08-07T00:10:58","slug":"mylan-pharmaceuticals-voluntarily-recalls-insulin-glargine-injection-pens","status":"publish","type":"post","link":"https:\/\/www.molllawgroup.com\/blog\/mylan-pharmaceuticals-voluntarily-recalls-insulin-glargine-injection-pens\/","title":{"rendered":"Mylan Pharmaceuticals Voluntarily Recalls Insulin Glargine Injection Pens"},"content":{"rendered":"<p><img loading=\"lazy\" decoding=\"async\" class=\"alignleft size-full wp-image-2814\" src=\"https:\/\/www.molllawgroup.com\/blog\/wp-content\/uploads\/2022\/08\/woman-g38859c667_640.jpg\" alt=\"woman-g38859c667_640\" width=\"640\" height=\"427\" srcset=\"https:\/\/www.molllawgroup.com\/blog\/wp-content\/uploads\/2022\/08\/woman-g38859c667_640.jpg 640w, https:\/\/www.molllawgroup.com\/blog\/wp-content\/uploads\/2022\/08\/woman-g38859c667_640-300x200.jpg 300w, https:\/\/www.molllawgroup.com\/blog\/wp-content\/uploads\/2022\/08\/woman-g38859c667_640-180x120.jpg 180w\" sizes=\"auto, (max-width: 640px) 100vw, 640px\" \/>Early in July, Mylan Pharmaceuticals, Inc. <a href=\"https:\/\/www.fda.gov\/safety\/recalls-market-withdrawals-safety-alerts\/mylan-pharmaceuticals-inc-viatris-company-issues-voluntary-nationwide-recall-one-batch-insulin\" target=\"_blank\" rel=\"noopener\">voluntarily recalled<\/a> a batch of its prefilled Insulin Glargine Injection pens that come in 100 units\/mL, 3 mL. The pens include an insulin analog that is long-acting. Doctors prescribe it for glycemic controls in both adults and children who have type 1 or type diabetes. If you were injured or a loved one was lost due to uncontrolled blood sugar while using Insulin Glargine Injection pens or another type of insulin injection pen, you should call the experienced Chicago-based product liability lawsuits of Moll Law Group to see whether you have a viable claim. Billions have been recovered in lawsuits with which we\u2019ve been involved.<\/p>\n<p><strong>Call Moll Law Group About Your Insulin Injection Pen Claim<\/strong><\/p>\n<p>The pens in questions are packed five pens to a carton and sold to patients with diabetes. The carton includes information about the product, batch number, and the date the pens expire. The manufacturer recalled a batch that omitted a label on certain pens. Due to this lack of labeling, a patient could mix up the products and strengths of the unbranded pens. This, in turn, could lead to insufficient glycemic control, and either excessively high or low blood sugar.<\/p>\n<p>Biocon Sdn. Bhd made the affected pens, which are not branded and are interchangeable with biosimilar Insulin Glargine-yfgn pens. They affected pens were distributed by Mylan Specialty L.P in the United States between April 4 \u2013 May 5, 2022. The branded Semglee injection pen is not affected. While no adverse events have been reported so far, serious harm could be experienced by a patient who needs to control his or her insulin.<\/p>\n<p> <a href=\"https:\/\/www.molllawgroup.com\/blog\/mylan-pharmaceuticals-voluntarily-recalls-insulin-glargine-injection-pens\/#more-2813\" class=\"more-link\">Continue reading \u2192<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Early in July, Mylan Pharmaceuticals, Inc. voluntarily recalled a batch of its prefilled Insulin Glargine Injection pens that come in 100 units\/mL, 3 mL. The pens include an insulin analog that is long-acting. Doctors prescribe it for glycemic controls in both adults and children who have type 1 or type diabetes. If you were injured [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":2814,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[3],"tags":[154,155,62],"class_list":["post-2813","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-product-liability","tag-insulin-glargine-injection-pen","tag-malpractice","tag-product-liability"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Mylan Pharmaceuticals Voluntarily Recalls Insulin Glargine Injection Pens &#8212; Illinois Injury and Mass Tort Lawyer Blog &#8212; August 15, 2022<\/title>\n<meta name=\"description\" content=\"Early in July, Mylan Pharmaceuticals, Inc. voluntarily recalled a batch of its prefilled Insulin Glargine Injection pens that come in 100 units\/mL, 3 mL. &#8212; August 15, 2022\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.molllawgroup.com\/blog\/mylan-pharmaceuticals-voluntarily-recalls-insulin-glargine-injection-pens\/\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:title\" content=\"Mylan Pharmaceuticals Voluntarily Recalls Insulin Glargine Injection Pens &#8212; Illinois Injury and Mass Tort Lawyer Blog &#8212; August 15, 2022\" \/>\n<meta name=\"twitter:description\" content=\"Early in July, Mylan Pharmaceuticals, Inc. voluntarily recalled a batch of its prefilled Insulin Glargine Injection pens that come in 100 units\/mL, 3 mL. &#8212; August 15, 2022\" \/>\n<meta name=\"twitter:image\" content=\"https:\/\/www.molllawgroup.com\/blog\/wp-content\/uploads\/2022\/08\/woman-g38859c667_640.jpg\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Moll Law Group\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Mylan Pharmaceuticals Voluntarily Recalls Insulin Glargine Injection Pens &#8212; Illinois Injury and Mass Tort Lawyer Blog &#8212; August 15, 2022","description":"Early in July, Mylan Pharmaceuticals, Inc. voluntarily recalled a batch of its prefilled Insulin Glargine Injection pens that come in 100 units\/mL, 3 mL. &#8212; August 15, 2022","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.molllawgroup.com\/blog\/mylan-pharmaceuticals-voluntarily-recalls-insulin-glargine-injection-pens\/","twitter_card":"summary_large_image","twitter_title":"Mylan Pharmaceuticals Voluntarily Recalls Insulin Glargine Injection Pens &#8212; Illinois Injury and Mass Tort Lawyer Blog &#8212; August 15, 2022","twitter_description":"Early in July, Mylan Pharmaceuticals, Inc. voluntarily recalled a batch of its prefilled Insulin Glargine Injection pens that come in 100 units\/mL, 3 mL. &#8212; August 15, 2022","twitter_image":"https:\/\/www.molllawgroup.com\/blog\/wp-content\/uploads\/2022\/08\/woman-g38859c667_640.jpg","twitter_misc":{"Written by":"Moll Law Group","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.molllawgroup.com\/blog\/mylan-pharmaceuticals-voluntarily-recalls-insulin-glargine-injection-pens\/#article","isPartOf":{"@id":"https:\/\/www.molllawgroup.com\/blog\/mylan-pharmaceuticals-voluntarily-recalls-insulin-glargine-injection-pens\/"},"author":{"name":"Moll Law Group","@id":"https:\/\/www.molllawgroup.com\/blog\/#\/schema\/person\/53d2eb37d5d0cdb46ac61abacf05ce90"},"headline":"Mylan Pharmaceuticals Voluntarily Recalls Insulin Glargine Injection Pens","datePublished":"2022-08-15T10:10:06+00:00","mainEntityOfPage":{"@id":"https:\/\/www.molllawgroup.com\/blog\/mylan-pharmaceuticals-voluntarily-recalls-insulin-glargine-injection-pens\/"},"wordCount":591,"image":{"@id":"https:\/\/www.molllawgroup.com\/blog\/mylan-pharmaceuticals-voluntarily-recalls-insulin-glargine-injection-pens\/#primaryimage"},"thumbnailUrl":"https:\/\/www.molllawgroup.com\/blog\/wp-content\/uploads\/2022\/08\/woman-g38859c667_640.jpg","keywords":["insulin glargine injection pen","malpractice","product liability"],"articleSection":["Product Liability"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.molllawgroup.com\/blog\/mylan-pharmaceuticals-voluntarily-recalls-insulin-glargine-injection-pens\/","url":"https:\/\/www.molllawgroup.com\/blog\/mylan-pharmaceuticals-voluntarily-recalls-insulin-glargine-injection-pens\/","name":"Mylan Pharmaceuticals Voluntarily Recalls Insulin Glargine Injection Pens &#8212; Illinois Injury and Mass Tort Lawyer Blog &#8212; August 15, 2022","isPartOf":{"@id":"https:\/\/www.molllawgroup.com\/blog\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.molllawgroup.com\/blog\/mylan-pharmaceuticals-voluntarily-recalls-insulin-glargine-injection-pens\/#primaryimage"},"image":{"@id":"https:\/\/www.molllawgroup.com\/blog\/mylan-pharmaceuticals-voluntarily-recalls-insulin-glargine-injection-pens\/#primaryimage"},"thumbnailUrl":"https:\/\/www.molllawgroup.com\/blog\/wp-content\/uploads\/2022\/08\/woman-g38859c667_640.jpg","datePublished":"2022-08-15T10:10:06+00:00","author":{"@id":"https:\/\/www.molllawgroup.com\/blog\/#\/schema\/person\/53d2eb37d5d0cdb46ac61abacf05ce90"},"description":"Early in July, Mylan Pharmaceuticals, Inc. voluntarily recalled a batch of its prefilled Insulin Glargine Injection pens that come in 100 units\/mL, 3 mL. &#8212; August 15, 2022","breadcrumb":{"@id":"https:\/\/www.molllawgroup.com\/blog\/mylan-pharmaceuticals-voluntarily-recalls-insulin-glargine-injection-pens\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.molllawgroup.com\/blog\/mylan-pharmaceuticals-voluntarily-recalls-insulin-glargine-injection-pens\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.molllawgroup.com\/blog\/mylan-pharmaceuticals-voluntarily-recalls-insulin-glargine-injection-pens\/#primaryimage","url":"https:\/\/www.molllawgroup.com\/blog\/wp-content\/uploads\/2022\/08\/woman-g38859c667_640.jpg","contentUrl":"https:\/\/www.molllawgroup.com\/blog\/wp-content\/uploads\/2022\/08\/woman-g38859c667_640.jpg","width":640,"height":427},{"@type":"BreadcrumbList","@id":"https:\/\/www.molllawgroup.com\/blog\/mylan-pharmaceuticals-voluntarily-recalls-insulin-glargine-injection-pens\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.molllawgroup.com\/blog\/"},{"@type":"ListItem","position":2,"name":"Mylan Pharmaceuticals Voluntarily Recalls Insulin Glargine Injection Pens"}]},{"@type":"WebSite","@id":"https:\/\/www.molllawgroup.com\/blog\/#website","url":"https:\/\/www.molllawgroup.com\/blog\/","name":"Illinois Injury and Mass Tort Lawyer Blog","description":"Published by Illinois Injury and Mass Tort Attorney \u2014 Moll Law Group","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.molllawgroup.com\/blog\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.molllawgroup.com\/blog\/#\/schema\/person\/53d2eb37d5d0cdb46ac61abacf05ce90","name":"Moll Law Group","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/0febdc96ea554e620e775358f9d7e4fc56616188dfd2bb21b18c2fed4bd185a0?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/0febdc96ea554e620e775358f9d7e4fc56616188dfd2bb21b18c2fed4bd185a0?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/0febdc96ea554e620e775358f9d7e4fc56616188dfd2bb21b18c2fed4bd185a0?s=96&d=mm&r=g","caption":"Moll Law Group"}}]}},"jetpack_featured_media_url":"https:\/\/www.molllawgroup.com\/blog\/wp-content\/uploads\/2022\/08\/woman-g38859c667_640.jpg","_links":{"self":[{"href":"https:\/\/www.molllawgroup.com\/blog\/wp-json\/wp\/v2\/posts\/2813","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.molllawgroup.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.molllawgroup.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.molllawgroup.com\/blog\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.molllawgroup.com\/blog\/wp-json\/wp\/v2\/comments?post=2813"}],"version-history":[{"count":1,"href":"https:\/\/www.molllawgroup.com\/blog\/wp-json\/wp\/v2\/posts\/2813\/revisions"}],"predecessor-version":[{"id":2815,"href":"https:\/\/www.molllawgroup.com\/blog\/wp-json\/wp\/v2\/posts\/2813\/revisions\/2815"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.molllawgroup.com\/blog\/wp-json\/wp\/v2\/media\/2814"}],"wp:attachment":[{"href":"https:\/\/www.molllawgroup.com\/blog\/wp-json\/wp\/v2\/media?parent=2813"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.molllawgroup.com\/blog\/wp-json\/wp\/v2\/categories?post=2813"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.molllawgroup.com\/blog\/wp-json\/wp\/v2\/tags?post=2813"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}